Oxygenta Pharmaceutical Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)
Oxygenta Pharmaceutical Ltd · Outcome · 10 Nov 2026, 10:23 pm
Oxygenta Pharmaceutical Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 3,349 (+134.2% YoY | -9.5% QoQ) ■ EBITDA: 2.8 (Loss to Profit YoY | -94.8% QoQ) ■ EBITDA Margin (%): 0.1 (Loss to Profit YoY | -139 bps QoQ) ■ PAT: -274 (+44.5% YoY | -30.0% QoQ) ■ EPS (INR): -0.74 (+44.4% YoY | -29.8% QoQ)
Original exchange filing (PDF)
More announcements from Oxygenta Pharmaceutical Ltd
- Un-audited Financial Results for the Quarter and Half-year ended 30.09.2026. · 10 Nov 2026
- Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2026 ,inter alia, to consider and approve 1. Un-audited Financial .... · 10 Nov 2026
- Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. · 01 Oct 2026
- Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015. · 21 Aug 2026
- Outcome of 33rd Annual General Meeting held on 21.08.2026. · 21 Aug 2026
- Newspaper Advertisement for Notice of AGM scheduled to be held on 21st August, 2026. · 31 Jul 2026
- Intimation of Book Closure and Cut-off Date for the AGM · 30 Jul 2026
- Submission of 33rd Annual Report for the Financial Year 2025-26 under Regulation 34 of SEBI (LODR), Regulations, 2015 · 30 Jul 2026
